Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Hum Genet. 2014 Jan 2;94(1):135-43. doi: 10.1016/j.ajhg.2013.12.003.

Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease.

Author information

1
Institute of Human Genetics, University of Bonn, D-53127 Bonn, Germany.
2
Department of Neuropathology and Department of Epileptology, University of Bonn, D-53127 Bonn, Germany.
3
Cologne Center for Genomics (CCG), University of Cologne, D-50931 Cologne, Germany.
4
Department of Neuropathology, Neurozentrum, University of Freiburg, D-79106 Freiburg, Germany.
5
Department of Dermatology, University of Bonn, D-53127 Bonn, Germany.
6
Department of Dermatology, University of Regensburg, D-93053 Regensburg, Germany.
7
Department of Clinical Genetics, Odense University Hospital, DK-5000 Odense, Denmark.
8
Department of Dermatology and Allergy Centre, Odense University Hospital, DK-5000 Odense, Denmark.
9
Laboratory of Dermatohistopathology, D-88048 Friedrichshafen, Germany.
10
Department of Dermatology, Berne University Hospital, CH-3008 Berne, Switzerland.
11
Department of Dermatology, Medical University of Graz, A-8036 Graz, Austria.
12
Cologne Center for Genomics (CCG), University of Cologne, D-50931 Cologne, Germany; Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, 50674 Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany.
13
Dermatological Practice, D-33098 Paderborn, Germany.
14
Department of Dermatology, University Hospital Düsseldorf, D-40225 Düsseldorf, Germany.
15
Institute of Human Genetics, University of Bonn, D-53127 Bonn, Germany. Electronic address: regina.betz@uni-bonn.de.

Abstract

Dowling-Degos disease (DDD) is an autosomal-dominant genodermatosis characterized by progressive and disfiguring reticulate hyperpigmentation. We previously identified loss-of-function mutations in KRT5 but were only able to detect pathogenic mutations in fewer than half of our subjects. To identify additional causes of DDD, we performed exome sequencing in five unrelated affected individuals without mutations in KRT5. Data analysis identified three heterozygous mutations from these individuals, all within the same gene. These mutations, namely c.11G>A (p.Trp4*), c.652C>T (p.Arg218*), and c.798-2A>C, are within POGLUT1, which encodes protein O-glucosyltransferase 1. Further screening of unexplained cases for POGLUT1 identified six additional mutations, as well as two of the above described mutations. Immunohistochemistry of skin biopsies of affected individuals with POGLUT1 mutations showed significantly weaker POGLUT1 staining in comparison to healthy controls with strong localization of POGLUT1 in the upper parts of the epidermis. Immunoblot analysis revealed that translation of either wild-type (WT) POGLUT1 or of the protein carrying the p.Arg279Trp substitution led to the expected size of about 50 kDa, whereas the c.652C>T (p.Arg218*) mutation led to translation of a truncated protein of about 30 kDa. Immunofluorescence analysis identified a colocalization of the WT protein with the endoplasmic reticulum and a notable aggregating pattern for the truncated protein. Recently, mutations in POFUT1, which encodes protein O-fucosyltransferase 1, were also reported to be responsible for DDD. Interestingly, both POGLUT1 and POFUT1 are essential regulators of Notch activity. Our results furthermore emphasize the important role of the Notch pathway in pigmentation and keratinocyte morphology.

PMID:
24387993
PMCID:
PMC3882728
DOI:
10.1016/j.ajhg.2013.12.003
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center